Company Filing History:

6 out of 217

Actelion Pharmaceuticals Ltd

patents

3 out of 15

Oxford Glycosciences (uk) Ltd

Years Active: 2002-2015

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9199935 - Pharmaceutically active piperidine derivatives (2015-12-01),

2. 8729099 - Pharmaceutically active piperidine derivatives (2014-05-20),

3. 8624022 - Substituted aniline derivatives (2014-01-07),

4. 8071780 - 2-Hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide (2011-12-06),

5. 8071582 - Substituted aniline derivatives (2011-12-06),

6. 8022219 - 2-hydroxymethy1-3,4,5-trihydroxy-1-(4-pentyloxybenzyl) piperidine as glucosylceramide synthase (Gcs) inhibitor (2011-09-20),

7. 7994198 - Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase (2011-08-09),

8. 7985760 - Piperidinetriol derivatives as inhibitors of glycosyceramid synthase (2011-07-26),

9. 7678785 - Substituted aniline derivatives (2010-03-16),

10. 7105554 - Benzylidene thiazolidinediones and their use as antimycotic agents (2006-09-12),

11. 6740670 - Thiazolidine derivatives and its use as antifungal agent (2004-05-25),

12. 6335446 - Quinolinium- and pyridinium-based fluorescent dye compounds (2002-01-01),

Title: The Innovative Journey of Michael Glen Orchard

Introduction

Michael Glen Orchard, an accomplished inventor based in Oxfordshire, GB, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 12 patents, Orchard's work focuses on the development of novel compounds that are at the forefront of medicinal chemistry.

Latest Patents

Among his most recent achievements are his patents related to pharmaceutically active piperidine derivatives, specifically compounds of formula (I). These innovations highlight his commitment to advancing therapeutic options and improving patient outcomes.

Career Highlights

Throughout his career, Michael Glen Orchard has worked with notable companies such as Actelion Pharmaceuticals Ltd and Oxford Glycosciences (UK) Ltd. His experience in these organizations has played a crucial role in shaping his expertise in drug development and innovation.

Collaborations

Collaboration is key to innovation, and Orchard has partnered with esteemed colleagues such as Judi Charlotte Neuss and Andrew Carr. These collaborations have enabled the exchange of ideas and propelled advancements in their respective fields.

Conclusion

Michael Glen Orchard exemplifies the spirit of innovation in the pharmaceutical industry. His dedication to developing new therapeutic compounds and his collaborative efforts with fellow scientists underline the importance of teamwork in driving scientific discovery. As he continues on his innovative journey, the impact of his work will certainly benefit the healthcare sector and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.